|Bid||0.234 x 0|
|Ask||0.249 x 0|
|Day's Range||0.231 - 0.231|
|52 Week Range||0.212 - 0.400|
|Beta (3Y Monthly)||0.77|
|PE Ratio (TTM)||49.79|
|Forward Dividend & Yield||0.00 (1.43%)|
|1y Target Est||N/A|
This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about the link between company’s fundamentals and stock market performance. Read More...
This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about Return on Equity using a real-life example. Tianda PharmaceuticalsRead More...
June 28 (Reuters) - Tianda Pharmaceuticals Ltd: * FY REVENUE HK$361.6 MILLION, UP 84.9% * FINAL DIVIDEND OF HK0.35 CENTS PER SHARE * FY PROFIT ATTRIBUTABLE HK$10 MILLION VERSUS HK$12.4 MILLION Source text ...
Nov 21 (Reuters) - Tianda Pharmaceuticals Ltd: * Expects to record a decline in HY consolidated net profit attributable * Expected result due to fair value gain on derecognition of investments in redeemable ...